Professional Documents
Culture Documents
Location/Type
a. Type 1 gastric ulcers occur within the body of the stomach, most often along
the lesser curve at the incisura angularis along the locus minoris resistentiae.
This term refers to the histologic transition zone between the parietal cells of
the body and the gastrin-secreting cells of the antrum.
b. Type 2 gastric ulcers occur in the body of the stomach in combination with
duodenal ulcers. These ulcers are associated with acid oversecretion.
c. Type 3 gastric ulcers develop in the pyloric channel within 3 cm of the
pylorus. These ulcers are associated with acid oversecretion.
d. Type 4 gastric ulcers are located high in the stomach adjacent to the
esophagus.
e. Type 5 gastric ulcers are secondary to chronic NSAID and aspirin use and can
occur throughout the stomach.
Diagnosis
a. History of burning midepigastric pain that is stimulated by or follows
eating is a common presentation of gastric ulcers.
b. Upper gastrointeatinal (UGI) radiographs will show barium in an ulcer
crater.
c. Endoscopy detects 90% of ulcers and allows multiple biopsy samples to
be taken to rule out cancer or control bleeding.
d. H. pylori can be confirmed by urease breath test. tissue biopsy, or
antibody titer measurement.
Gastric ulcers and malignancy
a. A gastric ulcer does not degenerate into
carcinoma.
b. Gastric cancer will ulcerate in 25% of
cases. It is, therefore, mandatory to prove
that the ulcer is not carcinoma; 10% of
gastric ulcers are malignancies with
ulceration.
Treatment
a. Medical treatment of gastric ulcers is indicated initially. Most gastric ulcers will heal in 8—
12 weeks.
(1) Avoidance of ethanol, tobacco, and drugs that irritate the gastric mucosa is important.
(2) Histamine (H2) blockers are effective in healing gastric ulcers. Gastric ulcers associated
with NSAID use may not respond as well to H2 blockers.
(3) Proton pump inhibitors block the enzyme involved in the parietal cell secretion of acid.
(4) Antacid therapy in high doses has been demonstrated to be superior to placebo.
(5) Sucralfate is a sulfated sucrose that binds to the ulcer crater and protects for 6 hours.
(6) H. pylori treatment reduces the recurrence rates for gastric ulcer. Treatment requires
antisecretory agents (omeprazole, etc.}, antibiotics (amoxicillin or clarithromycin and
metronidazole) and/or bismuth. Ninety-percent cure rates are reported with dual antibiotic
and omeprazole treatment.
b. Surgical treatment is indicated in the following situations.
(1) Intractability. The ulcer fails to heal after 8-12 weeks of medical
therapy or recurs;
despite adequate medical therapy;
(l) Bleeding not controlled by endoscopy or medical therapy;
(3) Perforation;
(4) Gastric outlet obstruction;
(5) Malignancy cannot be excluded;
Operative procedures.
The operative procedure is determined by the type of ulcer, location,
and condition of the patient at the time of surgery.
a. Type 1 ulcer
Hemigastrectomy (excision of the distal 50% of the stomach with
excision of the ulcer) is historically the procedure of choice.
(1) Gastroduodenal anastomosis (Billroth I gastrectomy) is used for
reconstruction if the duodenum can be mobilized .
(l) Gastrojejunal anastomosis (Billroth II gustrectomy) is used for
reconstruction if the duodenum cannot be mobilized.
Types 2 and 3 ulcers
Vagotomy with antrectomy with extension to include axcision of the
ulcer. Vagotomy is necessary for pyloric channel ulcers or gastric ulcers
occurring with duodenal ulcers in order to reduce acid secretion.
Type 4 ulcer
(1) Antrectomy with extension of resection to include the ulcer;
(2) Antrectomy with wedge excision of the ulcer;
Type 5 ulcer
Surgical intervention for chemical-induced ulcers is reserved for
emergency situations (perforation and hemorrhage). Primary closure,
omental patch, or wedge excision combined with cessation of non-
steroidal anti-inflanunatory drugs and acetylsaliclyic acid (ASA) are
standard treatments.